EuropeanBiopharmaceuticalReview, Autumn 2017
Jon Weisberg at SAFE-BioPharma Association, Industry Advisor to EBR, gathered expert views on the potential effects of the EU General Data Protection Regulation, which goes live in spring 2018.
How voice assistant technology could revolutionise clinical trials
By Eva Grey
pharmaceutical-technology , 05 October2017
A new research collaboration aims to improve both data collection and patient engagement in clinical trials by harnessing the power of voice recognition.
Blockchain in pharma: opportunities in the supply chain
By Chris Lo
pharmaceutical-technology , 31October2017
Blockchain is the digital ledger technology that is sweeping through a number of industries on a wave of hype. Could the tech’s inherent transparency, security and reliability have applications in the pharmaceutical space? The answer seems to be an emphatic yes, but how could this underpinning technology improve the pharmaceutical supply chain?
GDPR could push pharmaceutical careers into the slow lane around the globe
November 28, 2017 by Pharma IQ
Senior pharmaceutical professionals are risking their career prospects due to a widespread lack of awareness on new data privacy legislation
Removing barriers to data sharing in pharmaceutical research and development
By Abi Millar
pharmaceutical-technology , 18december2017
Elsevier has donated its Unified Data Model to The Pistoia Alliance, a global, not-for-profit alliance that works to improve innovation in life sciences R&D. Abi Millar spoke to the two organisations to find out how it could become a common model of data sharing for better drug development
Voici un article très complet sur l’utilisation de la nouvelle spécification du standard CDASH en version 2 par Jozef AERTS.
CHIEF DATA OFFICER
Un poste d’avenir